Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02985866 · ClinicalTrials.gov registry record · NA
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
A NA study of Type1 Diabetes Mellitus, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 127
- Enrollment target
- 7
- Study locations
NCT02985866 is a NA study of Type1 Diabetes Mellitus that has completed, run by University of Virginia. The registered enrollment target is 127 participants, below the 738-participant average among 6 other Type1 Diabetes Mellitus trials with a reported enrollment target (83% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT02985866, a NA study of Type1 Diabetes Mellitus, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system.
Conditions Studied
Interventions
- DEVICE Artificial Pancreas
- OTHER Sensor Augmented Therapy
Study Locations (7)
California
- William Sansum Diabetes Center - Santa Barbara
- Stanford University - Stanford
Colorado
- Barbara Davis Center, University of Colorado - Aurora
Massachusetts
- Harvard University (Joslin Diabetes Center) - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Icahn School of Medicine at Mount Sinai - New York
Virginia
- University of Virginia Center for Diabetes Technology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2017-10-27 |
| Est. Completion | 2018-09-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02985866
The ClinicalTrials.gov registry entry for NCT02985866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 738-participant average among 6 other Type1 Diabetes Mellitus trials with a reported enrollment target (83% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Artificial Pancreas is the first listed.
NCT02985866 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02985866 about?
NCT02985866 is a clinical study titled "The International Diabetes Closed Loop (iDCL) Trial: Protocol 1". The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system.
What is the current status of trial NCT02985866?
This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2017-10-27. Estimated completion is 2018-09-04.
What conditions does trial NCT02985866 study?
This clinical trial studies the following conditions: Type1 Diabetes Mellitus.
What interventions are being tested in trial NCT02985866?
The interventions under investigation include: Artificial Pancreas (DEVICE), Sensor Augmented Therapy (OTHER).
Who is sponsoring clinical trial NCT02985866?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02985866 being conducted?
This trial has 7 study locations across California, Colorado, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
RECRUITING
-
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
ACTIVE NOT RECRUITING
-
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
COMPLETED · Phase 2
-
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
COMPLETED · Phase 1
-
The Insulin-Only Bionic Pancreas Bridging Study
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.